In many cases, mutant p53 proteins have prolonged half-life and accumulate within cancer cells.38 Many frequent mutations may also confer so-called gain-of-function activities to mutant p53.38 We observed strong synergy with APR-246 and cisplatin in all cancer cells harboring homozygous hotspot mutations (Table 1a). This evidence concerns the gene TP53 and cancer.